SBFM - Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
SBFM - Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies
Sunshine Biopharma Inc. (NASDAQ: SBFM ) on Wednesday announced it advanced its lead Coronavirus drug candidate into IND-enabling studies. The company had previously published laboratory results on its library of compounds in August 2024 and more recently in March 2026. Background and Compound Research The company said